Arm’s main risk is not product relevance but value capture. The architecture moat is real, yet returns can disappoint if
hyperscalers negotiate away economics,
AGI CPU slips from roadmap to deployments,
Arm China limits visibility or collections, or investors stop paying a scarcity multiple for a business that is becoming broader but also more contested.